Translate.One President Peter Smith told Slator that Translate.One and Enable2 were introduced in late 2023.
“Since then, we have cultivated a strong and collaborative relationship, recognizing the synergy between our companies and the potential to create greater value together,” Smith said.
Enable2, which is based in Shipley, England, caters to “non-English-speaking people and communities.” In addition to on-site interpreting, Enable2 uses a proprietary platform to book and facilitate telephonic (OPI) and video (VRI) interpreting. Its offerings reportedly include more than 140 “languages and dialects.”
Slator 2023 Language Industry M&A and Funding Report
This 61-page report provides an in-depth analysis of mergers, acquisitions, and funding in the language services industry in 2023.
Smith noted that Enable2’s capabilities will “significantly enhance” the existing interpreting services offered by Translate.One.
Legal staffing, court reporting, and eDiscovery are among the parent company’s law-related services. Translate.One’s offerings, meanwhile, range from translation and interpreting to multimedia localization.
Enable 2 started as a spin-off from the UK’s National Health Service (NHS) and has since maintained a strong presence in hospitals and other healthcare settings.
Smith explained that Enable2 Founder and Managing Director Liz Weatherill will stay with the company post-sale, adding, “Over time we will probably integrate Enable2 into the Translate.One brand.”
